Pre-Filled Syringes Europe 2018
17 January 2018 - 18 January 2018
Join the calendar event highlight for the medical device industry at Europe's leading 10th annual conference and exhibition on Pre-Filled Syringes when it returns to Central London on 17th and 18th January 2018. Pre-Filled Syringes Europe will once again provide a perfect platform to discuss new advancements and showcase the latest innovations to keep you at the forefront of a dynamic and booming market.
What will the future of the pharmaceutical industry look like following an increase in the number of generics and biosimilars hitting the market; a trend in the rise of self-administered drugs and personalised medicine; and Britain’s recent decision to leave Europe? How will these changes affect the PFS industry?
Building on the success of its sell-out global 2017 PFS series of events which saw 100+ attendees join shows in London, Boston and San Diego, the agenda for Pre-Filled Syringes Europe 2018 has been carefully tailored to arm you with the key requirements and tools to adapt to an ever-changing medical landscape in areas that are critical to those working within parenteral drug delivery and injectable devices.
Featured Speakers:
• Alphons Fakler, Group Head Risk Management, Novartis Pharma
• Bettine Boltres, Technical Account Manager, West Pharmaceutical Services
• Elizabeth Baker, Group Manager Licensing Division, MHRA
• Marcel Mueller, Device Project Leader, Novartis
• Cedric Gysel, Staff Device Engineer, Janssen
• Carsten Worsoe, Principal Scientist, CMC Analytical Support, Novo Nordisk
• Vikas Jaitely, Senior Manager CMC Regulatory Intelligence and Pharmaceutical Science, Merck
• Susanne Joerg, Head of Formulation Development, Lonza
• Orla Downes, Head of Business Development Unit, Barts Health Pharmaceuticals
• Barry Knight, Device Program Lead, UCB Celltech
• Sudeshna Dutta Ray, Senior Engineer, Advanced Device Technology and Innovation, Amgen
• Alexander Jung, Senior Manager, Technology and Innovation, Drug Delivery and Devices, Boehringer Ingelheim
• Christian Dechant, Primary Packaging Director, Boehringer Ingelheim
Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK
http://www.pre-filled-syringes.com/ddt
7th annual Pharmaceutical Microbiology
22 January 2018 - 23 January 2018
SMi’s 7th annual Pharmaceutical Microbiology UK conference will provide attendees essential indicators for Quality Assurance and Quality Control whilst presenting that latest information on protecting pharmaceutical and healthcare products from spoilage by microorganisms, and protecting patients and consumers.
This year’s event will provide an in-depth overview of the function of the pharmaceutical microbiologist and what they need to know, from regulatory filing and GMP, to laboratory design and management, and risk assessment tools and techniques. These key aspects are discussed through a series of dedicated presentations, keynote sessions and workshops, with topics covering biofilms, validation, data analysis, bioburden, toxins, microbial identification, mycoplasma testing, and contamination control.
Holiday Inn Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/pharmaceutical-microbiology?utm_medium=www.pharma-microbiology.com&utm_source=P-230&utm_campaign=DDToday
15th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology
24 January 2018 - 26 January 2018
HTC-15 will be the premier conference in hyphenated separation techniques in 2018. With its rich history of successful meetings since 1990 HTC will be hosted at Cardiff City Hall in the heart of the capital city of Wales. The conference has always delivered presentations from internationally renowned experts both from Industry and Academia. The HTC 15 Event will be enhanced through joint chairing of the Scientific Committee by Tom Lynch and Peter Schoenmakers.
Cardiff City Hall, Wales, United Kingdom
https://www.ilmexhibitions.com/htc/
Festival of Genomics London 2018
30 January 2018 - 31 January 2018
After the success of our London Festival in 2017, we are now raring to go once more. We will return to our hometown for the third Festival of Genomics London on the 30th & 31st January 2018.
And we've got some good news... registration is now open for you to secure your FREE Festival Pass. Register online at http://www.festivalofgenomicslondon.com/ddt using promotion code EM9
The Festival is for anyone generating, using, or studying genomic information. We have designed the show to offer insights and value for the full breadth of the genomics community – from academia, biopharma, healthcare organisations, investment firms, patient organisations and solution providers.
Our numerous stages will be packed with presentations and panels from some of the industry’s most influential figures and prestigious organisations.
In 2018 we will hone in on discussion topics such as: Cancer genomics, cardiovascular health, clinical genomics, CRISPR, drug development, enabling data, genetic counselling, immuno-oncology, implementation of genomics in the clinic, infectious diseases, patient engagement and much more.
If you’re using genomics to drive forward R&D, drug development or the diagnosis and treatment of disease then the Festival is the place to get inspired and informed.
Join us on our mission to deliver the benefits of genomics faster!
Use promotion code EM9 to register for free at http://www.festivalofgenomicslondon.com/ddt
ExCeL Royal Victoria Dock, London
http://www.festivalofgenomicslondon.com/ddt
5th UK Pharmacogenetics and Stratified Medicine Network Annual Open Meeting
21 March 2018
The UK Pharmacogenetics and Stratified Medicine Network is dedicated to developing collaborative partnerships between healthcare professionals, academic researchers, industry partners, regulatory bodies and patients to synergise research into stratified medicine across the UK and support its adoption into the clinic.
30 Euston Square, London NW1 2FB
http://www.uk-pgx-stratmed.co.uk/index.php
Drug Discovery for Rare Diseases
28 March 2018
Rare diseases, or diseases that affect only a small percentage of the population, have been growing in significance and prominence in recent years. According to the National Institutes of Health, there are nearly 7000 rare diseases and more than 25 million Americans who are affected. Approximately 80% of these rare diseases are genetic in origin. Cambridge Healthtech Institute's symposium on Drug Discovery for Rare Diseases will bring together leading scientists, clinicians, executives and experts who are deeply involved in bringing to market the treatments for such rare disorders. This symposium will bring to light some of the new drug targets, and peptide and oligonucleotide-based drug modalities that are being pursued. This unique one-day event will bring together people from diverse backgrounds to tackle translational challenges and to discuss potential opportunities in this field. The goal is to help attendees and sponsors meet scientific and technical experts who are involved in rare disease research to exchange ideas and set up collaborations.
Boston Marriott, Cambridge, MA, USA
http://optcongress.com/rare-diseases/
ELRIG Discovery Technologies 2018
23 May 2018
ELRIG is pleased to invite you to the inaugural Discovery Technologies Meeting, to be held at Alderley Park, Macclesfield, UK, on 23rd May 2018. This exciting new ELRIG meeting will focus on the application of novel and emerging technologies that are reshaping the drug discovery paradigm.
For 2018, the conference will include two parallel sessions:
Advances in Mass Spectrometry
Advances in Organ-on-a-Chip Technologies
During this 1-day conference, researchers from top academic and industrial laboratories will discuss advances and case studies in these two rapid evolving research areas. In addition to the outstanding speaker program, you will have the opportunity to take part in vendor workshops, network at the exhibition and gain strategic insights into potential solutions for increasing the success of drug discovery and development in your organisation.
Alderley Park, Cheshire, UK
http://elrig.org/portfolio/discovery-technologies-2018/
Current trends in drug discovery – young scientists and tomorrow’s medicines
07 June 2018
The organisers encourage abstract submissions from final year undergraduate, postgraduate and postdoctoral researchers working in all areas of biology, chemistry, chemical biology, genetics and drug distribution relevant to drug discovery and from early career scientists working in the biotech and pharmaceutical industry.
A prize will be awarded for the best oral presentation and the best poster presentation given by a young scientist.
A joint meeting of the Society for Medicines Research and the British Pharmacological Society
Oral presentation abstract submission deadline: Friday 23 February 2018
Poster presentation abstract submission deadline: Friday 30 March 2018
King's College London, Bush House, 30 Aldwych, London WC2R 4BG
https://www.smr.org.uk/smr/Meetings/20180607/Default.asp
BioForward
04 October 2018
BioForward is a unique, high-quality, international conference, focussed on creating and developing a practical roadmap for early stage, emerging, and developing life sciences companies to achieve sustainable business success and growth. The one-day conference will feature:
• Panel discussions on the major issues and challenges in developing biotech, pharmaceutical and medtech products
• ‘How To’ sessions discussing a range of issues with key influencers and experts
• A trade exhibition featuring a range of service providers who can accelerate business growth
• Plenty of partnering and networking opportunities
This new, annual event is aimed at professionals who are keen to gain the knowledge, skills, connectivity, and support necessary to maximise their chances of success and efficiently navigate through the various development phases to market and beyond.
John Harris, CEO of OBN, said:
“As the leader of a growing life sciences company it is critical to make the right decisions at the right time, minimising risk and maximising the chance of success. BioForward provides an unrivalled environment to access the very best support and advice available, from a wide variety of sources. We are excited to be launching this event, and the level of interest already expressed emphasises that BioForward will be addressing a significant and unmet need in the sector.”
Aston Webb Building, University of Birmingham, UK
https://www.bioforward.co.uk/whatson
Inv€$tival 2018 Home - Biotech and Money
13 November 2018
LSX (formerly Biotech and Money) connects corporates to capital and the Inv€$tival Showcase is our most direct way of showcasing the latest innovative and investable private and public life science opportunities to our investor network.
In exclusive partnership with Jefferies LLC, the Inv€$tival Showcase spans 4-tracks and will feature the most exciting companies across key sub-sectors within life sciences, including immuno-oncology, neuroscience & CNS, cell and gene therapies, digital health and medtech.
The global list of presenting companies will include the most exciting and innovative, as well as investable, companies looking to raise capital or profile with investors; brought together through both LSX's and Jefferies' investor networks.
Hilton Waldorf, London, UK
https://www.biotechandmoney.com/investival-showcase